Advertisement
Screener

COCRYSTAL PHARMA, INC. (COCP) Proceeds from Issuance of Debt

1.2 / 5 stars · 14/60 Roast Me

COCRYSTAL PHARMA, INC. Proceeds from Issuance of Debt

COCRYSTAL PHARMA, INC. (COCP) reported Proceeds from Issuance of Debt of $1.00 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfDebt · last filed 2018-08-09

  • COCRYSTAL PHARMA, INC. proceeds from issuance of debt for the quarter ending 2018-06-30 was $0.00.
  • COCRYSTAL PHARMA, INC. proceeds from issuance of debt for the quarter ending 2018-03-31 was $1.00M.
Period endProceeds from Issuance of Debt 3 monthProceeds from Issuance of Debt 6 month
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$1.00M
10-Q · filed 2018-08-09
2018-03-31$1.00M
10-Q · filed 2018-05-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
NextCure, Inc. (NXTC)United States$0.024B-0.15
Rocket One Inc. (RKTO)United States$0.019B
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62